CHD9 anticorps

N° du produit ABIN6567348

Détail du produit anti-CHD9 anticorps

Antigène: CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CHD9 est non-conjugé

Application: Western Blotting (WB)

Purification: Affinity purification

Immunogène: Recombinant protein of human CHD9

Isotype: IgG

Information d'application

Indications d'application: WB 1:500 - 1:2000

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: Buffer: PBS with 0.02 % sodium azide, 50 % glycerol,  pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur CHD9

Antigène: CHD9 (Chromodomain Helicase DNA Binding Protein 9 (CHD9))

Autre désignation: CHD9 (CHD9 Produits)

Synonymes: anticorps CReMM, anticorps ad013, anticorps cremm, anticorps kish2, anticorps pric320, anticorps AD013, anticorps KISH2, anticorps PRIC320, anticorps 1810014J18Rik, anticorps 9030205D12Rik, anticorps A330063D19Rik, anticorps mKIAA0308, anticorps chromodomain helicase DNA binding protein 9, anticorps Chd9, anticorps CHD9, anticorps chd9

Sujet:

Synonyms: 1810014J18Rik,9030205D12Rik,A330063D19Rik,AD-013,AD013,ATP dependent helicase CHD9,ATP-dependent helicase ,CHD 9,CHD9,Chromatin related mesenchymal modulator,chromatin remodeling factor ,Chromatin remodeling factor CHROM1,Chromodomain helicase DNA binding protein 9,Ciprofibrate bound protein p240,CReMM,KIAA0308,KISH2,Kismet homolog 2,mKIAA0308,Peroxisomal proliferator activated receptor A interacting complex 320 kDa protein,PPAR alpha interacting complex protein 320 kDa,PPAR-alpha-interacting complex protein 320 k,PPAR{gamma}-interacting cofactor 320 kDa,PRIC320,Proteinx0008

Poids moléculaire:

Observed_MW: 300kDa

Calculated_MW: 324kDa/326kDa

ID gène: 80205

UniProt: Q3L8U1

Pathways: Regulation of Lipid Metabolism by PPARalpha